Mondias Naturals signs exclusive research agreement with Premier Tech for CELEXT07: a leading figure in horticulture and agriculture

Mondias Natural Products Inc. (NHP.V) specializing in evidence-based botanical products for the healthcare and bio-agriculture markets announces that it has entered into a Research Agreement with Premier Tech, a multinational company operating in Horticulture and Agriculture, Systems and Automation, and Environmental Technologies to conduct studies on Mondias' CELEXT07 potential as a novel biostimulant and biopesticide agent. Under the terms of the Exclusive Agreement dated September 20, 2019, Mondias will supply quantities of CELEXT07 product material and Premier Tech will conduct a series of experiments to study various biological mechanisms with the product. The exclusivity period will last for 180 days from the initiation of the studies by Premier Tech. As part of the Agreement and depending on results and outcomes, Mondias and Premier Tech, will be working in good faith on commercial terms for CELEXT07.   

 

Dr. Patrick Frankham , Mondias CEO stated that "we are delighted to be working with Premier Tech, a North American leader in Horticulture and Agriculture, to confirm that CELEXT07 has potential to significantly increase crop yields by stimulating growth and increasing plant immunity." Dr. Frankham also added "previous studies conducted on cannabis plants indicated that CELEXT07 could be of value in an emerging industry where grey mould and powdery mildew diseases can impact margins and be a safety concern for consumers. Therefore, creating a commercial product and evaluating the business case with the expertise of Premier Tech is a great opportunity for Mondias."

 

Mark Murphy, Vice-President Strategic Development of Premier Tech's Horticulture and Agriculture Group stated that "we are encouraged by the early results that CELEXT07 has demonstrated and we welcome the opportunity to explore further commercial possibilities with the product and with Mondias Naturals." 

 

CELEXT07 is patent pending on herbal phytosanitary composition and methods for the prevention and treatment of plant infections in Australia, Brazil, Canada , China , European Union, and the US and the World Intellectual Property Organization (WIPO). Mondias has invested in research programs in collaboration with McGill's Faculty of Agricultural and Environmental Sciences to develop CELEXT07.